CompoAtlas

利汝活力膠囊食品

利汝活力膠囊食品 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

Registration number
1015024640
Chinese name
利汝活力膠囊食品
English name
LIBIWOMAN CAPSULES
Type
Imported tablets and capsules
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
德效國際有限公司
Registration date
2012-08-23
Published validity end
2027-08-23

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
PLACENTA POWDERPLACENTA POWDERNot identified
SOYBEAN GERMS POWDERSOYBEAN GERMS POWDERNot identified
COLLAGEN PEPTIDECOLLAGEN PEPTIDENot identified
CRANBERRY EXTRACTCRANBERRY EXTRACTNot identified
CHICKEN CARTILAGE COLLAGENCHICKEN CARTILAGE COLLAGENNot identified
ROYAL JELLYROYAL JELLYGelée royale
RED WINE EXTRACT POWDERRED WINE EXTRACT POWDERNot identified
GRAPE SEED EXTRACTGRAPE SEED EXTRACTNot identified
COENZYME Q10COENZYME Q10Ubiquinone
GREEN TEA POWDERGREEN TEA POWDERNot identified
GELATINGELATINNot identified
PURIFIED WATERPURIFIED WATERNot identified
TITANIUM DIOXIDETITANIUM DIOXIDENot identified
BEET RED COLORBEET RED COLORNot identified
BLUEBERRY COLORBLUEBERRY COLORNot identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Original register data

View published fields and their variants
Product name
利汝活力膠囊食品
Active ingredients
PLACENTA POWDER;;SOYBEAN GERMS POWDER;;COLLAGEN PEPTIDE;;CRANBERRY EXTRACT;;CHICKEN CARTILAGE COLLAGEN;;ROYAL JELLY;;RED WINE EXTRACT POWDER;;GRAPE SEED EXTRACT;;COENZYME Q10;;GREEN TEA POWDER;;GELATIN;;PURIFIED WATER;;TITANIUM DIOXIDE;;BEET RED COLOR;;BLUEBERRY COLOR;;
Valid until
1160823
Registration number
1015024640
Licence holder
德效國際有限公司
Registration date
1010823
Published reference
DHC0A150246402
Published English name
LIBIWOMAN CAPSULES

Official source

View the official register, number 1015024640

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • ROYAL JELLY
    Read the warning, when it applies and the studies cited

    ROYAL JELLY

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Contraindications

    Do not use if you have a history of asthma or allergies (TGA 2001; Leung et al. 1997; Harwood et al. 1996; Laporte et al. 1996; Thien et al. 1996; Leung et al. 1995; Peacock et al. 1995; Bullock 1994).

    8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Leung et al. 1997; Laporte et al. 1996; Thien et al. 1996; Leung et al. 1995; Peacock et al. 1995).

    5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 24 April 2026

  • COENZYME Q10
    Read the warning, when it applies and the studies cited

    Coenzyme Q10 (UBIQUINONE-10)

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood pressure medication (Rosenfeldt et al. 2007; Singh et al. 1999).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products providing more than 100 mg of Coenzyme Q10 per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Engelsen et al. 2003; Landbo and Almdal 1998; Spigset 1994).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Migraine prophylaxis/prevention.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if migraine frequency increases and associated nausea and vomiting persist or worsen.

    Health Canada monograph dated 31 January 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line